UB-221
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UB-221, covering 2022-10-07 to 2022-10-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous Urticaria [Phase 2]